Tuesday, October 31, 2017 10:15 PM ET
Insiders at Vertex Pharmaceuticals (VRTX) Make Significant Stock Sales
Three insiders — Ian F Smith, Officer, Amit Sachdev, Officer, and Dr Jeffrey Chodakewitz, Officer — today, sold 175,000 shares of Vertex Pharmaceuticals having a market value of approximately $25,385,103, as revealed in form 4 documents filed with the SEC. These are the first insider buy/sell trades in the past 90 days. Adding the most recent activity to this 90-day history indicates insider trades have averaged 58,333 shares per transaction.
Over the last 90 days, the number of insider buy/sell trades at Vertex Pharmaceuticals is higher than its 269-company peer group average. The Bio Therapeutic Drugs peer group saw 325 buy/sell trades during this period for an average of 1.2 transactions per company. However, the number of shares traded per transaction by Vertex Pharmaceuticals insiders is lower than its peers. Within the peer group there were 26,310,161 shares purchased and 12,304,393 shares sold with company insiders acquiring 68,656 shares on average over this time period.
In determining significant insider buying and selling, trades reported to the SEC that involve awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers have been eliminated in data sourced to evaluate and write this story.
Today’s Insider Activity
* Ian F Smith, Officer, sold 75,000 shares
* Amit Sachdev, Officer, sold 40,000 shares
* Dr Jeffrey Chodakewitz, Officer, sold 60,000 shares
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at firstname.lastname@example.org. Copyright 2017 UpTick Data Technologies. All rights reserved.